Cargando…

Assessing Oncologists’ Adoption of Biomarker Testing in Metastatic Colorectal Cancer Using Real-World Data

BACKGROUND: Despite national guideline recommendations for universal biomarker testing (KRAS, NRAS, BRAF, and mismatch repair and microsatellite instability [MMR/MSI]) in all patients with metastatic colorectal cancer (mCRC), little is known regarding adherence to these recommendations in routine pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iyer, Pritish, Deng, Mengying, Handorf, Elizabeth A, Nakhoda, Shazia, Dotan, Efrat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664970/ https://www.ncbi.nlm.nih.gov/pubmed/36149298 http://dx.doi.org/10.1093/jncics/pkac065

Ejemplares similares

Dosing Schedules of Gemcitabine and nab-Paclitaxel for Older Adults With Metastatic Pancreatic Cancer
por: Winer, Arthur, et al.
Publicado: (2021)

Bridging the Knowledge Gap for Older Patients With CLL on Ibrutinib
por: Nakhoda, Shazia, et al.
Publicado: (2023)

Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists
por: McNamara, Donna M., et al.
Publicado: (2019)

Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer
por: Liu, Shuai, et al.
Publicado: (2022)

Optimal Management of Patients with Advanced or Metastatic Cholangiocarcinoma: An Evidence-Based Review
por: Ioffe, Dina, et al.
Publicado: (2021)

Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists
por: Klink, Andrew J, et al.
Publicado: (2022)

Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
por: Jain, Rishi, et al.
Publicado: (2020)

The Real-World Practice of Fruquintinib for Chinese Patients with Metastatic Colorectal Cancer
por: Song, Yan, et al.
Publicado: (2021)

Bevacizumab Treatment for Metastatic Colorectal Cancer in Real-World Clinical Practice
por: Dinu, Ioana Mihaela, et al.
Publicado: (2023)

Traveling With Cancer: A Guide for Oncologists in the Modern World
por: Heng, Sharon, et al.
Publicado: (2019)

GERIATRIC ASSESSMENT ADOPTION IN COMMUNITY CANCER CENTERS: TRENDS, BARRIERS, AND RECOMMENDATIONS
por: Plotkin, Elana, et al.
Publicado: (2019)

Updates in the Role of Checkpoint Inhibitor Immunotherapy in Classical Hodgkin’s Lymphoma
por: Nakhoda, Shazia, et al.
Publicado: (2022)

Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study
por: Leicher, Laura W., et al.
Publicado: (2016)

Real‐world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
por: Xu, Ting, et al.
Publicado: (2023)

Inventory of oncologists’ unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer
por: Engelhardt, Ellen G., et al.
Publicado: (2018)

BRAF(V600E) Metastatic Colorectal Cancer: Perspective from a Patient, a Caregiver, and an Oncologist
por: Gourdin, Guillaume, et al.
Publicado: (2023)

Real-World Breast Cancer Patient Follow-Up Practices by Medical Oncologists in India—A Survey Report
por: Patel, Amol, et al.
Publicado: (2022)

Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
por: Arisi, Maria F., et al.
Publicado: (2022)

Comparison of the efficacy and safety of fruquintinib and regorafenib in the treatment of metastatic colorectal cancer: A real-world study
por: Deng, Ya-Ya, et al.
Publicado: (2023)

Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data
por: Martin, James M, et al.
Publicado: (2022)

Prospective Comparison of Geriatric Assessment and Provider’s Assessment of Older Adults With Metastatic Breast Cancer in the Community
por: Seedor, Rino S, et al.
Publicado: (2022)

A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study
por: Procaccio, Letizia, et al.
Publicado: (2021)

Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study
por: Pericay, Carles, et al.
Publicado: (2023)

Psychological distress and moral injury to oncologists and their patients during COVID-19 pandemic
por: Rashid, Shazia, et al.
Publicado: (2021)

Radiation Oncologists’ Perceptions of Adopting an Artificial Intelligence–Assisted Contouring Technology: Model Development and Questionnaire Study
por: Zhai, Huiwen, et al.
Publicado: (2021)

Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study
por: Deng, Ting, et al.
Publicado: (2023)

Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO)
por: Dervenis, Christos, et al.
Publicado: (2016)

Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population
por: Lam, Ka-On, et al.
Publicado: (2019)

Real‐World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
por: Patel, Anuj K., et al.
Publicado: (2019)

Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer
por: Liu, Xiu, et al.
Publicado: (2023)

Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer
por: Aggarwal, Himani, et al.
Publicado: (2023)

The role of the oncologist
por: Rossi, M, et al.
Publicado: (2010)

On thin ice: barriers to adoption of surveillance for patients with stage I testicular seminoma. Survey of US radiation oncologists
por: Jain, Aditya, et al.
Publicado: (2018)

Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography–Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study
por: Parsons, Susan K., et al.
Publicado: (2023)

Association Between Regorafenib Dose and Efficacy Against Metastatic Colorectal Cancer in a Real-World Setting
por: Hatori, Masahiro, et al.
Publicado: (2021)

Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis
por: Schulz, Martin S., et al.
Publicado: (2022)

Time to treatment initiation and its impact on real‐world survival in metastatic colorectal cancer and pancreatic cancer
por: Gbolahan, Olumide, et al.
Publicado: (2022)

Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study
por: González-Montero, Jaime, et al.
Publicado: (2023)

Patterns of Biomarker Use in Cancer Treatment Among Medical Oncologists in the Philippines
por: Catedral, Lance Isidore, et al.
Publicado: (2020)

A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)
por: Scott, Aaron J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b80itt0ks8arvbhftamth04b37